Epidemiological and Immunological Characteristics at the Time of HIV Diagnosis for HIV/AIDS Cohort Registrants Representative of HIV-Infected Populations in Korea

Osong Public Health and Research Perspectives

Volumn 3, Issue 2, 2012, Pages 100-106

  Lee, Jin Hee ^a   Kim, Seung Hyun ^a   Wang, Jin Sook ^a   Sung, Kyoung Mi ^a   Kim, Sung Soon ^a   Kee, Mee Kyung ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

HIV infected population; HIV AIDS Cohort; South Korea

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; EPIDEMIOLOGICAL DATA; FEMALE; HIV TEST; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; KOREA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; SEX RATIO; VIRUS TRANSMISSION;

EID: 84862645070     PISSN: 22109099     EISSN: 22109110     Source Type: Journal    
DOI: 10.1016/j.phrp.2012.04.002     Document Type: Article

References (17)

1. Korea Centers for Disease Control and Prevention Guideline for HIV/AIDS Control, KCDC 2012, p.14-17.
2. KCDC and UNDP, Korea The Social and Economic Impacts of HIV/AIDS Infection in Korea, The Report of International AIDS Symposium 2004, p. 177-189.
3. Ministry for Health Welfare and Family Affairs. Information field: The data of laws, Bioethics.
4. Thierfelder C., Weber R., Elzi L., et al. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Med 2012 Feb, 13(2):118-126.
5. Swiss H.I.V. Cohort study. Cohort profile: the Swiss HIV Cohort Study. Int J Epidemiol 2010 Oct, 39(5):1179-1189.
6. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 2000, 355:1131-1137. Collaborative Group on AIDS Incubation.
7. CASCADE Collaboration Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1 infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr 2003 Sep, 34(1):76-83.
8. Korea Centers for Disease Control and Prevention Guideline for HIV/AIDS Control, KCDC 2012, p.81-115.
9. Kee MK, Wang JS, Kim SH, et al. The profile of Korea HIV/AIDS Cohort Study, The 10th International Congress on AIDS in Asia and the Pacific; 26-30 August, 2011; Busan, Republic of Korea, OP-02254.
10. Lee J.H., Kim G.J., Choi B.S., et al. Increasing late diagnosis in HIV infection in South Korea: 2000-2007. BMC Public Health 2010, 10:411.
11. UNAIDS Global Report, UNAIDS Report on the Global AIDS Epidemic 2010.
12. Lee J.H., Hong K.J., Wang J.S., et al. Estimation of hospital-based HIV seroprevalence as a nationwide scale by novel method; 2002-2008 in Korea. BMC Public Health 2010, 10:739.
13. Detels R., Jacobson L., Margolick J., et al. The multicenter AIDS Cohort Study, 1983 to. Public Health 2012 Mar, 126(3):196-198.
14. Bacon M.C., von Wyl V., Alden C., et al. The women's interagency HIV study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005 Sep, 12(9):1013-1019.
15. Osih R.B., Taffe P., Rickenbach M., et al. Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV Cohort Study. AIDS Res Hum Retroviruses 2010 Nov, 26(11):1239-1246.
16. Dudley J., Jin S., Hoover D., et al. The Multicenter AIDS Cohort Study: retention after 9§ years. Am J Epidemiol 1998 Aug, 142(3):323-330.
17. CASCADE Collaboration. Concerted Action on Seroconversion to AIDS and Death in Europe, CASCADE 1997.